1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow iVascular S.L.U.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy Angiolite: Sirolimus-eluting stent, Xience: Everolimus-eluting stent, 1-month DAPT - Coronary Artery Disease | Phase 3 | Active not recruiting | iVascular S.L.U. | 2312 | 2023-10-13 | 2026-05-15 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1) · Standard of Care (1)
Belgium (1) · France (1) · Spain (1)